Cargando…
MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cells
MYCN is an oncogenic driver in neural crest-derived neuroblastoma and medulloblastoma. To better understand the early effects of MYCN activation in a neural-crest lineage context, we profiled the transcriptome of immortalized human retina pigment epithelial cells with inducible MYCN activation. Gene...
Autores principales: | Zanotti, Sofia, Vanhauwaert, Suzanne, Van Neste, Christophe, Olexiouk, Volodimir, Van Laere, Jolien, Verschuuren, Marlies, Van der Meulen, Joni, Mus, Liselot M., Durinck, Kaat, Tilleman, Laurentijn, Deforce, Dieter, Van Nieuwerburgh, Filip, Hogarty, Michael D., Decaesteker, Bieke, De Vos, Winnok H., Speleman, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280219/ https://www.ncbi.nlm.nih.gov/pubmed/34262099 http://dx.doi.org/10.1038/s41598-021-93863-9 |
Ejemplares similares
-
In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors
por: Vanhauwaert, Suzanne, et al.
Publicado: (2018) -
Publisher Correction: In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors
por: Vanhauwaert, Suzanne, et al.
Publicado: (2019) -
Haplotyping pharmacogenes using TLA combined with Illumina or Nanopore sequencing
por: Tilleman, Laurentijn, et al.
Publicado: (2022) -
Targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies’ adaptive sampling
por: Deserranno, Koen, et al.
Publicado: (2023) -
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
por: Nunes, Carolina, et al.
Publicado: (2022)